Back to Research Home

AMSAmerican Shared Hospital Service

Health Care · Medical Specialities · Micro

$1.260.00%
As of 23 Oct 2026Mkt cap $10M
Stage 13
AVOID
Fundamentals
19.4/75
Technical
5.0/15
Independent
24.4/90

GCAE viewstructural technical damage is a hard non-actionable condition

Price

1M
−13.7%
3M
−18.2%
6M
−5.3%
1Y
−45.6%

Financials & valuation

Cached filing evidence · as of 2026-10-02

Valuation

P/E
—Hist median 5.1x
Forward P/E
—No validated forward-estimate source
Price / FCF
—
FCF yield
—

Quality

ROIC
—
Operating margin
-9.9%
FCF margin
-16.2%
Current ratio
0.8x

Growth

Revenue growth
−0.9%Latest FY YoY
Revenue CAGR
+12.3%
EPS CAGR
—
FCF CAGR
—

Capital

Share-count trend
+1.7%3Y annualised
Net debt
$18M5.9x OCF

Annual trend

CAGR 2021–2025
+12.3%
Latest · 2025
$0B
YoY
−0.9%
Quality Research
NOT FLAGGED
Acceleration Radar
NOT FLAGGED
THE ONE
NOT FLAGGED
Final / Opportunity
NOT FLAGGED

Key takeaway

structural technical damage is a hard non-actionable condition

Unresolved question

No reliable unresolved question is available from the current committed evidence.

Watch next

  • Next earnings · 2026-11-12
More details & evidence

Production decision

Stage 13
AVOID
Technical state
damaged
Rotation
tailwind
Evidence
fresh

Presentation freshness

Stage 11 market
2026-10-23 · Massive
Financial cache
2026-10-02
Quality Research
NOT FLAGGED
THE ONE
NOT FLAGGED

Authority

Company page
Presentation only
Scores
Frozen GCAE production outputs
Research
Research-only lanes; no score override
Private portfolio
Not loaded